Thymosin α1 — Immune system tuner

What it is:

28-amino-acid peptide. Endogenous fragment from prothymosin α (thymus-derived). Synthetic version used in medicine and by biohackers.

What it does:

• Boosts T-cell activity (CD4+, CD8+)
• Enhances NK cell function
• Increases MHC class I expression (better antigen presentation)
• Improves interferon response
• Brings balance to immune signaling — not overstimulation

Use cases:

✅ Chronic viral infections — HBV, HCV, HIV
✅ Seasonal flu & colds — shortens duration, softens symptoms, supports recovery (esp. in older or immunocompromised)
✅ COVID — studied as adjunct in hospitalized patients
✅ Cancer — NSCLC, melanoma, HCC (used with chemo or checkpoint inhibitors)
✅ Sepsis & critical care — reduces immune paralysis
✅ Immunosenescence — helps aging immune systems fight back
✅ Chronic fatigue & low-resilience states
✅ General immune support — high stress, travel, burnout

Dosage:

• Standard: 1.6 mg SC, twice per week
• Flu/cold: Daily 1.6 mg x 5–7 days at first signs
• Long-term immune modulation: cycles of 4–12 weeks
• Half-life ≈ 2 hours, but immune effects persist

Side effects:

Very low. Injection site irritation is most common. No major systemic issues reported.

Other notes:

• Not an “immune booster” in the noisy supplement sense — more like an immune tuner
• No direct antiviral effect — it sharpens your body’s own response
• Common in anti-aging stacks, especially in winter
• Synergistic with other immune or recovery peptides (BPC-157, TB-500, GH)

If you’re prone to colds, sick too often after travel or stress, or getting older and slower to bounce back, Thymosin α1 is worth considering. It won’t make you feel superhuman overnight, but it tilts the balance back toward resilience.

A bit of science: mdpi.com/1420-3049/28/8/3539